HLS
HEALIUS FPO [HLS]
Healthcare · ASX Small Cap
$0.6700 -2.2%
Updated 2026-03-02 · Scores refresh every scan
Appeared in 2 consecutive scans→ Score +10First seen: 2026-02-25
Score Breakdown
Technical57
Catalyst50
Sentiment50
Fundamental87
Momentum41
Risk Gate25
Active Signals
Bullish Signals
- RSI oversold (potential bounce)
- Stochastic oversold
- Near support level (potential bounce)
- Cash positive / operating cashflow positive
- Low P/S ratio (0.4x)
- EPS estimates revised upward (+10pts)
- Near 52-week low (3% of range)
- Elevated short interest (5.9%)
- CANSLIM I: Institutional ownership (96%)
- Altman Z-Score in distress zone (1.35 < 1.81)
- Days to cover very high (10.8)
- ASX200 bullish (+1.5% 5d)
- RBA cutting (+2pts)
Risk Signals
- Price below MAs (downtrend)
- Below 200-day MA (long-term downtrend)
- Negative profit margins (-12%)
- Insufficient sentiment data (defaulting to neutral)
- Neutral/mixed sentiment
Recent Catalysts
NONE Change in substantial holding
NONE Healius announces 1H 2026 results
NONE Half Year 2026 Results Presentation
Recent ASX Announcements
| 2026-02-23 | Change in substantial holding |
| 2026-02-17 | Healius announces 1H 2026 results PRICE SENSITIVE |
| 2026-02-17 | Half Year 2026 Results Presentation PRICE SENSITIVE |
| 2026-02-17 | Half Yearly Report and Accounts PRICE SENSITIVE |
| 2026-02-09 | Change in substantial holding from MUFG |
Key Metrics
$497.4M
Market Cap
4.0M
Avg Volume
1.0x
Vol Ratio
$0.66 — $1.64
52-Week Range
5.9%
Short Interest
N/A
Cash Runway
-69.3%
ROE
-12.3%
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | neutral | Float: 79% |
| L | Leader vs Laggard | laggard | RS: -7 |
| I | Institutional Sponsorship | pass | Inst: 96% |
| M | Market Direction | pass | Bullish |
Sector: Healthcare
Ranked #4 of 119 · Sector avg: 51
View all Healthcare signals →